LUPPI, Fabrizio
 Distribuzione geografica
Continente #
NA - Nord America 8.866
EU - Europa 7.140
AS - Asia 3.894
SA - Sud America 568
AF - Africa 72
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 7
Totale 20.559
Nazione #
US - Stati Uniti d'America 8.688
IT - Italia 3.926
SG - Singapore 1.314
GB - Regno Unito 1.234
CN - Cina 911
VN - Vietnam 436
BR - Brasile 424
SE - Svezia 410
HK - Hong Kong 380
DE - Germania 311
FR - Francia 283
FI - Finlandia 217
BD - Bangladesh 205
UA - Ucraina 193
RU - Federazione Russa 187
TR - Turchia 123
NL - Olanda 117
IN - India 112
CA - Canada 99
KR - Corea 84
BG - Bulgaria 63
ID - Indonesia 63
AR - Argentina 53
MX - Messico 48
JP - Giappone 45
IQ - Iraq 43
IE - Irlanda 33
BE - Belgio 31
ZA - Sudafrica 23
PL - Polonia 22
ES - Italia 21
EC - Ecuador 20
PK - Pakistan 20
VE - Venezuela 20
AE - Emirati Arabi Uniti 16
IR - Iran 15
SA - Arabia Saudita 14
CL - Cile 13
CO - Colombia 12
LT - Lituania 12
MY - Malesia 12
NP - Nepal 12
AU - Australia 11
CH - Svizzera 11
MA - Marocco 11
PY - Paraguay 10
TW - Taiwan 10
AT - Austria 9
TH - Thailandia 9
TN - Tunisia 9
HR - Croazia 8
JO - Giordania 8
KE - Kenya 8
PH - Filippine 8
AZ - Azerbaigian 7
LV - Lettonia 7
PE - Perù 7
EU - Europa 6
IL - Israele 6
LB - Libano 6
CR - Costa Rica 5
DK - Danimarca 5
DZ - Algeria 5
KZ - Kazakistan 5
NO - Norvegia 5
PT - Portogallo 5
BO - Bolivia 4
CY - Cipro 4
DO - Repubblica Dominicana 4
RO - Romania 4
RS - Serbia 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
UZ - Uzbekistan 4
BZ - Belize 3
CZ - Repubblica Ceca 3
EE - Estonia 3
EG - Egitto 3
ET - Etiopia 3
JM - Giamaica 3
NI - Nicaragua 3
PR - Porto Rico 3
SI - Slovenia 3
BH - Bahrain 2
BY - Bielorussia 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
KG - Kirghizistan 2
KW - Kuwait 2
LU - Lussemburgo 2
MN - Mongolia 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
QA - Qatar 2
SN - Senegal 2
AL - Albania 1
Totale 20.538
Città #
Ashburn 911
Southend 887
Singapore 865
Fairfield 792
Santa Clara 766
Chandler 478
Woodbridge 476
Houston 397
San Jose 380
Hong Kong 369
Ann Arbor 308
Milan 285
Rome 285
Seattle 274
Wilmington 265
Jacksonville 251
Cambridge 244
Dearborn 233
Nyköping 222
Beijing 203
London 164
Helsinki 162
New York 159
Council Bluffs 158
Hefei 155
Modena 155
Los Angeles 133
Ho Chi Minh City 121
Hanoi 113
Chicago 105
San Diego 100
The Dalles 94
Florence 73
Naples 70
Dallas 68
Seoul 67
Shanghai 64
Sofia 60
Bologna 58
Princeton 56
Izmir 55
Buffalo 53
Palermo 53
Eugene 52
Catania 48
Jakarta 47
Lauterbourg 47
São Paulo 46
Bari 45
Salt Lake City 45
Moscow 43
Orem 43
Redwood City 40
Munich 39
Columbus 38
Bremen 33
Turin 33
Genoa 32
Verona 32
Phoenix 31
Boardman 30
Tokyo 29
Brussels 28
Chennai 27
Frankfurt am Main 27
Montreal 27
Toronto 26
Cagliari 25
Padova 25
Da Nang 22
Atlanta 21
Mexico City 21
Baghdad 20
Salerno 20
Guangzhou 19
Mountain View 19
Falls Church 18
Haiphong 18
Bergamo 17
Pisa 17
Tampa 17
Boston 16
Brescia 16
Manchester 16
Parma 16
Brooklyn 15
Reggio Emilia 15
Treviso 15
Warsaw 15
Des Moines 14
Elk Grove Village 14
Fremont 14
Turku 14
Buenos Aires 13
Cinisello Balsamo 13
Miano 13
Mumbai 13
Denver 12
Dublin 12
Johannesburg 12
Totale 12.622
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.865
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 491
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 443
"Velcro-type" crackles predict specific radiologic features of fibrotic interstitial lung disease 423
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 417
Clusterin decreases oxidative stress in lung fibroblasts exposed to cigarette smoke 385
Effectiveness of pulmonary rehabilitation in patients with INTERSTITIAL LUNG DISEASE of different etiology: a multicenter prospective study 378
Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests 375
Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist 363
Morbidity and Mortality in Patients with Idiopathic Pulmonary Fibrosis Undergoing Diagnostic Surgical Lung Biopsy 363
Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments 362
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 356
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 350
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 346
Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors 336
Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review 334
Treatment of chronic obstructive pulmonary disease and its comorbidities 334
Clinical performance of a commercial real-time PCR assay for Aspergillus DNA detection in serum samples from high-risk patients: comparison with a galactomannan enzyme immunoassay 329
Role Of The QFT-IT Assay For The Diagnosis Of Latent Tuberculosis Infection Among Adult Immigrants 321
Complex chronic co-morbidities of COPD 320
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 317
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 314
Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis. 312
Prognostic role of clusterin in resected adenocarcinomas of the lung. 304
Best supportive care for idiopathic pulmonary fibrosis: Current gaps and future directions 304
Clusterin (CLU) and lung cancer 302
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 301
Acute exacerbations of chronic obstructive pulmonary disease: are antibiotics needed? 297
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 297
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 295
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation 292
Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy 290
Management of Idiopathic Pulmonary Fibrosis 289
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 289
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 288
Occurrence of idiopathic pulmonary fibrosis during immunosuppressive treatment: a case report 285
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 272
A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis 265
Pulmonary comorbidities associated with chronic obstructive pulmonary disease 255
Pulmonary Carcinosarcoma Arising in the Framework of an Idiopathic Pulmonary Fibrosis 252
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 252
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 247
Validation of a Method for Automatic Detection of Lung Sounds in Fibrotic Interstitial Lung Disease 245
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 244
Etiology and Level of Lung Derangement Do Not Affect the Beneficial Effect of Pulmonary Rehabilitation in Patients with Interstitial Lung Diseases 241
Challenges in idiopathic interstitial lung disease 233
Co-trimoxazole effect on human alveolar macrophages of AIDS patients 225
High serum levels of silica nanoparticles in systemic sclerosis patients with occupational exposure: Possible pathogenetic role in disease phenotypes 209
CHARACTERIZATION OF ANTI-MPO POSITIVE INTERSTITIAL LUNG DISEASE. CLINICAL-SEROLOGIC AND RADIOLOGIC FEATURES AND SURVIVAL 205
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 198
Therapeutic approaches to idiopathic pulmonary fibrosis 184
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 169
Progression and prognosis of interstitial pneumonia with autoimmune features: a longitudinal, prospective, multi-centre study 161
Medicina personalizzata e fibrosi polmonare idiopatica 161
Interstitial lung disease and anti-myeloperoxidase antibodies: not a simple association 153
Malattie infiltrative diffuse del polmone 152
Erratum to: Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement (Clinical Rheumatology, (2017), 36, 6, (1261-1268), 10.1007/s10067-017-3601-1) 141
Disease progression across the spectrum of idiopathic pulmonary fibrosis: A multicentre study 118
Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and Differences 118
Efectiveness of Nintedanib in Progressive Pulmonary Fibrosis Assessed by Progression Criteria: An Italian, Observational, Multicenter Study 105
Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis From the Classification Criteria for Anti‐Synthetase Syndrome Project 73
Prevalence, incidence and mortality of interstitial lung disease in patients with Sjogren disease: data from the prospective observational “EMERGE” study 71
Impact of Dosing on Functional and Clinical Outcomes of Patients With Progressive Pulmonary Fibrosis Treated With Nintedanib: Data From a Real-World, Multicentric, Italian Study 49
Recommendations for radiotherapy in patients with lung cancer and interstitial lung disease: A Delphi consensus process of the Italian association of radiotherapy and clinical oncology (AIRO) 45
Multidisciplinary management of interstitial lung disease in autoimmune rheumatic diseases: an Italian Delphi consensus 13
Totale 20.723
Categoria #
all - tutte 66.802
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.802


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.458 86 116 113 107 62 92 64 84 171 100 260 203
2022/20232.122 193 178 119 181 203 237 123 198 239 112 192 147
2023/20242.061 115 139 156 199 270 224 201 225 60 95 174 203
2024/20253.315 198 112 115 263 593 432 282 211 338 136 270 365
2025/20265.719 345 191 395 599 902 443 771 254 557 519 406 337
2026/2027172 172 0 0 0 0 0 0 0 0 0 0 0
Totale 20.723